Company Comparison
Foundation Medicine vs BioAnalytics
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Foundation Medicine | BioAnalytics |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | Boston, Massachusetts | Boston |
| Founded | 2010 | — |
| Status | Active | Active |
| Last Funding Stage | IPO | Series B |
| Total Funding | $456M | $55M |
| Valuation | — | — |
What They Build
Foundation Medicine
Foundation Medicine, Inc. is an American company based in Boston, Massachusetts, which develops, manufactures, and sells genomic profiling assays based on next-generation sequencing technology for solid tumors, hematologic malignancies, and sarcomas.
BioAnalytics
Boston-based biotech company developing analytics and data solutions for the life sciences industry.
Key Investors
Foundation Medicine
BioAnalytics
No investors listed.
Sector Overlap
Both Foundation Medicine and BioAnalytics operate in Biotech.
Browse all Biotech companies →Websites
The operating system for private capital.
Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.
14-day free trial. No credit card required.